NEW YORK – TwinStrand Biosciences said Tuesday it has closed a $16 million Series A financing round.
Madrona Venture Group led the round, joined by Alexandria Venture Investments, Ridgeback Capital, and Sahsen Ventures. TwinStrand will use the funds to accelerate its commercial pipeline, grow corporate infrastructure, and pursue pharmaceutical partnerships.